V
Vicarious Surgical Inc
NYSE:RBOT
Vicarious Surgical Inc
NYSE:RBOT
Price:
0.85
USD
-4.49%
Market Closed
Market Cap:
$6.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
V
|
Vicarious Surgical Inc
NYSE:RBOT
|
US |
|
Investec PLC
LSE:INVP
|
UK |
|
Perrigo Company PLC
NYSE:PRGO
|
IE |
|
TVS Srichakra Ltd
NSE:TVSSRICHAK
|
IN |
Income Statement
Earnings Waterfall
Vicarious Surgical Inc
Vicarious Surgical Inc
Income Statement
Vicarious Surgical Inc
Vicarious Surgical Inc
Currency: USD
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
22
N/A
|
0
N/A
|
8
N/A
|
8
N/A
|
14
+66%
|
22
+60%
|
22
-2%
|
22
N/A
|
|
| Gross Profit | |||||||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(19)
|
0
|
(7)
|
0
|
(13)
|
0
|
(19)
|
0
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
3
N/A
|
0
N/A
|
1
N/A
|
0
N/A
|
1
N/A
|
0
N/A
|
3
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||||||||
| Operating Expenses |
(13)
|
(15)
|
(19)
|
(24)
|
(38)
|
(51)
|
(64)
|
(77)
|
(80)
|
(84)
|
(87)
|
(86)
|
(62)
|
(74)
|
(64)
|
(68)
|
(54)
|
(67)
|
(43)
|
(56)
|
|
| Selling, General & Administrative |
(3)
|
(4)
|
(6)
|
(8)
|
(16)
|
(23)
|
(29)
|
(36)
|
(36)
|
(37)
|
(36)
|
(35)
|
(33)
|
(30)
|
(28)
|
(27)
|
(26)
|
(27)
|
(24)
|
(21)
|
|
| Research & Development |
(10)
|
(11)
|
(13)
|
(16)
|
(22)
|
(28)
|
(34)
|
(41)
|
(44)
|
(47)
|
(50)
|
(51)
|
(48)
|
(44)
|
(42)
|
(40)
|
(40)
|
(40)
|
(38)
|
(35)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
19
|
0
|
7
|
0
|
12
|
0
|
19
|
0
|
|
| Operating Income |
(13)
N/A
|
(15)
-19%
|
(19)
-23%
|
(24)
-28%
|
(38)
-58%
|
(51)
-34%
|
(64)
-24%
|
(77)
-21%
|
(80)
-4%
|
(84)
-5%
|
(87)
-3%
|
(86)
+1%
|
(81)
+6%
|
(74)
+8%
|
(71)
+5%
|
(68)
+5%
|
(67)
+1%
|
(67)
N/A
|
(63)
+7%
|
(56)
+10%
|
|
| Pre-Tax Income | |||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
1
|
1
|
3
|
4
|
4
|
4
|
4
|
3
|
3
|
3
|
2
|
2
|
1
|
|
| Total Other Income |
0
|
0
|
0
|
(37)
|
3
|
64
|
81
|
115
|
84
|
17
|
5
|
12
|
5
|
9
|
6
|
1
|
0
|
4
|
0
|
1
|
|
| Pre-Tax Income |
(13)
N/A
|
(15)
-20%
|
(19)
-23%
|
(61)
-220%
|
(35)
+42%
|
13
N/A
|
18
+41%
|
38
+115%
|
5
-86%
|
(64)
N/A
|
(78)
-22%
|
(69)
+12%
|
(71)
-3%
|
(61)
+14%
|
(61)
+1%
|
(62)
-2%
|
(63)
-1%
|
(61)
+3%
|
(59)
+3%
|
(53)
+10%
|
|
| Net Income | |||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(13)
|
(15)
|
(19)
|
(61)
|
(35)
|
13
|
18
|
38
|
5
|
(64)
|
(78)
|
(69)
|
(71)
|
(61)
|
(61)
|
(62)
|
(63)
|
(61)
|
(59)
|
(53)
|
|
| Net Income (Common) |
(13)
N/A
|
(15)
-20%
|
(19)
-23%
|
(61)
-220%
|
(35)
+42%
|
13
N/A
|
18
+41%
|
38
+115%
|
5
-86%
|
(64)
N/A
|
(78)
-22%
|
(69)
+12%
|
(71)
-3%
|
(61)
+14%
|
(61)
+1%
|
(62)
-2%
|
(63)
-1%
|
(61)
+3%
|
(59)
+3%
|
(53)
+10%
|
|
| EPS (Diluted) |
-0.11
N/A
|
-0.13
-18%
|
-0.16
-23%
|
-0.51
-219%
|
-0.29
+43%
|
0.09
N/A
|
0.14
+56%
|
0.32
+129%
|
0.04
-88%
|
-0.51
N/A
|
-0.62
-22%
|
-0.44
+29%
|
-14.57
-3 211%
|
-10.43
+28%
|
-10.35
+1%
|
-10.52
-2%
|
-10.69
-2%
|
-10.3
+4%
|
-9.97
+3%
|
-8.94
+10%
|
|
Switch to:
Switch to:
See Also
Discover More
